Ticagrelor Dose 1a + Dose 2a

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease

Drug Information

Target Indication

Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease

Clinical Trial

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

AZN

AstraZeneca PLC

Related Pipeline

Irritable Bowel Syndrome With Constipation (IBS-C)

Muscle Invasive Bladder Cancer

Asthma, Exercise-Induced

Affective Psychosis, Bipolar

Carcinoma, Non-Small-Cell Lung